Ascendis Pharma A/S - ADR (ASND)

Q1 2021 13F Holders as of 3/31/2021

Type / Class
Equity / ADR
Shares outstanding
55.6M
Number of holders
171
Total 13F shares, excl. options
52.7M
Shares change
-1.5M
Total reported value, excl. options
$6.79B
Value change
-$267M
Put/Call ratio
1.04
Number of buys
99
Number of sells
-73
Price
$128.88

Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2021

215 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2021.
Ascendis Pharma A/S - ADR (ASND) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 52.7M shares of 55.6M outstanding shares and own 94.75% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.41M shares), Artisan Partners Limited Partnership (6.05M shares), FMR LLC (5.38M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.07M shares), BAKER BROS. ADVISORS LP (3.54M shares), WELLINGTON MANAGEMENT GROUP LLP (3.49M shares), JANUS HENDERSON GROUP PLC (3.17M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.87M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.7M shares), and Vivo Capital, LLC (1.66M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.